Paracetamol Use During Pregnancy—A Call for Precautionary Action. Issue 3 (March 2022)

• Record Type: Journal Article
• Authors: Bauer, Ann Z.; Swan, Shanna H.; Kriebel, David; Liew, Zeyan; Taylor, Hugh S.; Bornehag, Carl-Gustaf; Andrade, Anderson M.; Olsen, Jørn; Jensen, Rigmor H.; Mitchell, Rod T.; Skakkebaek, Niels E.; Jégou, Bernard; Kristensen, David M.
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 3(2022)
• Page Start: 133
• Page End: 134
• Publication Date: 2022-03
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/OGX.0000000000001019
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Nat Rev Endocrinol 2021;17:757–766) Paracetamol, otherwise known as acetaminophen, is the active ingredient in over 600 prescription and nonprescription analgesic and antipyretic medications. Worldwide and in the United States, more than 50% and 65% of pregnant women use acetaminophen, respectively.